ZARVY

Levolin 100mcg Rotacaps contains Levosalbutamol (Levalbuterol) 100mcg, a fast-acting beta-2 adrenergic agonist bronchodilator for inhalation therapy in asthma and COPD. It delivers medication directly to the lungs for rapid relief of bronchospasm, wheezing, shortness of breath, and airway constriction. Compared with regular salbutamol, Levosalbutamol is associated with fewer tremors and palpitations. The Rotacaps dry-powder formulation enables efficient lung delivery without propellants and can be easier to use than traditional inhalers. It’s also available via an online pharmacy channel for convenient access.

Foracort 200 Inhaler contains Formoterol Fumarate (6mcg) and Budesonide (200mcg), an effective combination therapy for asthma and chronic obstructive pulmonary disease (COPD). Formoterol: A long-acting beta-2 adrenergic agonist (LABA) that relaxes airway muscles, improving airflow and preventing bronchoconstriction. Budesonide: An inhaled corticosteroid (ICS) that reduces lung inflammation and prevents asthma attacks. Foracort 200 is recommended for long-term asthma control and COPD maintenance therapy, helping to prevent wheezing, shortness of breath, and airway inflammation.

Duolin Inhaler - 200 MDI contains Levosalbutamol 50mcg and Ipratropium 20mcg, a combination bronchodilator therapy for asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol (Levalbuterol): Selective beta-2 adrenergic agonist, relaxes airway muscles, reduces bronchospasm, and improves airflow. Ipratropium: An anticholinergic agent that blocks muscarinic receptors, preventing mucus overproduction and airway constriction. Together, they provide dual-action bronchodilation, ideal for COPD, chronic bronchitis, emphysema, and asthma exacerbations. The Metered Dose Inhaler (MDI) ensures precise dosing for consistent symptom control and fast relief during acute respiratory distress, including exercise-induced bronchospasm.

Formost 200 Inhaler is a combination controller inhaler for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol Fumarate (6mcg): A long-acting beta-2 adrenergic agonist (LABA) that relaxes airway muscles and maintains airflow for up to 12 hours. Mometasone (200mcg): An inhaled corticosteroid (ICS) that reduces airway inflammation and mucus production. This metered-dose inhaler (MDI) delivers precise medication per puff, helping maintain stable lung function, reduce exacerbations, and lower the need for rescue inhalers.

Foracort 200 Rotacaps contain Formoterol Fumarate (6mcg) and Budesonide (200mcg), making it an effective dry powder inhalation therapy for asthma and chronic obstructive pulmonary disease (COPD). Formoterol: A long-acting beta-2 agonist (LABA) that relaxes airway muscles, improving airflow and preventing bronchoconstriction. Budesonide: An inhaled corticosteroid (ICS) that reduces lung inflammation and prevents asthma attacks. Foracort 200 Rotacaps are recommended for long-term asthma control and COPD maintenance, preventing wheezing, breathlessness, and airway inflammation.

Serevent Evohaler is the original brand inhaler manufactured by GSK, containing Salmeterol 25mcg, a long-acting beta-2 adrenergic agonist (LABA) used for the prevention of asthma symptoms and long-term management of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways to improve breathing and is effective for up to 12 hours. This inhaler is not suitable for acute asthma attacks but is essential in maintaining airway patency and controlling chronic symptoms.

Indamet 160 Rotacaps is a generic version of Onbrez, formulated with Indacaterol 160mcg, an ultra-long-acting beta-2 agonist (LABA) indicated for the once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD). Manufactured by Glenmark Pharmaceuticals, this rotacap-based inhalation therapy is designed to provide 24-hour bronchodilation, helping to ease airflow obstruction and chronic breathlessness in patients with COPD.

Pilomax (Pilocarpine 5mg) is an oral cholinergic agonist used to reduce elevated intraocular pressure (IOP) in patients with glaucoma, particularly those with acute angle-closure glaucoma or open-angle glaucoma requiring adjunctive therapy. By stimulating muscarinic receptors, Pilocarpine enhances aqueous humor outflow through the trabecular meshwork, thereby lowering IOP and helping prevent optic nerve damage. Pilomax tablets are typically prescribed when topical therapies alone are insufficient or during acute management where rapid miosis and pressure reduction are needed.

Serevent Accuhaler is an original branded medication manufactured by GSK, containing Salmeterol 50mcg, a long-acting β2-adrenergic receptor agonist (LABA). It is formulated as an inhalation powder in a user-friendly Accuhaler device, designed to deliver a consistent dose directly to the lungs. This medication plays a crucial role in managing chronic respiratory diseases by promoting bronchodilation and improving airflow in patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD). As a maintenance therapy, Serevent Accuhaler helps prevent breathing difficulties, wheezing, and chest tightness. Its long-acting nature provides symptom relief for up to 12 hours, making it especially effective for nighttime symptom control and long-term airway management. It is not intended for immediate relief of acute asthma attacks, but rather as part of a regular respiratory care routine.

Onbrez 300 Breezhaler is an original inhalation medication by Novartis, containing Indacaterol 300mcg, a once-daily ultra-long-acting β2 agonist (LABA). It delivers powerful and sustained bronchodilation for the maintenance treatment of severe COPD (Chronic Obstructive Pulmonary Disease), including chronic bronchitis and emphysema. The Breezhaler® device ensures precise and efficient pulmonary delivery. In respiratory care, Onbrez 300 stands alongside treatments such as Omnacortil (for inflammation) and antibiotics like Zithromax, Vibramycin, or Novamox, which are often used when COPD patients suffer bacterial exacerbations. Many patients also find this product conveniently available via an online pharmacy.

Levolin 50mcg Inhaler is a bronchodilator containing Levosalbutamol 50mcg, which is widely used to relieve bronchospasms and improve airflow in patients with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. As a beta-2 adrenergic agonist, Levosalbutamol works by relaxing the smooth muscles in the airways, making it easier to breathe. It provides rapid relief from wheezing, shortness of breath, and chest tightness. Unlike standard Salbutamol, Levosalbutamol is considered to have a more selective action on bronchial muscles, reducing the risk of unwanted side effects such as tremors and palpitations. It is commonly prescribed for asthma maintenance therapy, exercise-induced bronchoconstriction, and acute episodes of airway obstruction. This metered-dose inhaler (MDI) ensures precise dosing for effective symptom control.

Levolin 1.25mg Respules contains Levosalbutamol 1.25mg, a potent bronchodilator used to manage respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). It is a beta-2 adrenergic agonist, which helps relax the airway muscles, providing quick relief from bronchospasms, wheezing, shortness of breath, and airway constriction. This formulation is designed as a nebulized solution for use with a nebulizer device, ensuring deep lung penetration for effective and immediate relief. It is particularly beneficial for patients with severe respiratory distress, including acute asthma attacks and COPD exacerbations. Levosalbutamol, also known as Levalbuterol, is an advanced form of Salbutamol (Albuterol), offering similar bronchodilation with fewer side effects, such as reduced heart palpitations and muscle tremors. The Respules formulation makes it easy to administer, especially in pediatric and elderly patients who may struggle with using metered-dose inhalers (MDIs) or dry powdered inhalers (DPIs).

Levolin 0.63mg Respules is a bronchodilator solution containing Levosalbutamol 0.63mg, a highly effective medication used to relieve bronchospasms in asthma and chronic obstructive pulmonary disease (COPD). It belongs to the class of short-acting beta-2 adrenergic agonists (SABAs), which work by relaxing the airway muscles and facilitating smooth and unrestricted breathing. This medication is delivered via nebulization, making it an ideal choice for patients who struggle with inhalers or require continuous airway relief. It provides rapid symptom control, ensuring that individuals experiencing acute breathing difficulties can receive immediate relief from wheezing, shortness of breath, and airway obstruction. Compared to regular Salbutamol, Levosalbutamol has been found to provide similar efficacy with a lower incidence of side effects such as tremors and palpitations. Respules are convenient for pediatric and elderly patients, ensuring deep lung penetration for enhanced respiratory function.

Foracort 100 Rotacaps is a combination inhalation therapy containing Formoterol Fumarate (6mcg) and Budesonide (100mcg), designed to provide effective and long-lasting relief for asthma and chronic obstructive pulmonary disease (COPD). This dual-action inhaler combines Formoterol, a long-acting beta-2 agonist (LABA), and Budesonide, a corticosteroid, to manage airway inflammation and bronchospasms. Formoterol works as a bronchodilator, relaxing the airway muscles and allowing smooth breathing for up to 12 hours, making it particularly beneficial for patients with exercise-induced bronchospasms, persistent asthma, and COPD exacerbations. Budesonide, on the other hand, is a potent inhaled corticosteroid that reduces airway inflammation, preventing asthma attacks and frequent respiratory distress. Foracort 100 Rotacaps is specially formulated for use in a dry powder inhaler (DPI), ensuring efficient drug delivery without the need for propellants, making it easier to inhale for individuals who struggle with conventional metered-dose inhalers (MDIs). It is a controller medication, meaning it is not for immediate relief but rather for long-term asthma and COPD management.

Formonide 100 Inhaler contains Formoterol Fumarate 6mcg (a long-acting bronchodilator) and Budesonide 100mcg (a corticosteroid), making it an effective combination inhaler for managing asthma and chronic obstructive pulmonary disease (COPD). Formoterol works by relaxing airway muscles, making breathing easier, while Budesonide reduces airway inflammation and prevents asthma attacks. This inhaler is recommended for long-term asthma control and COPD symptom management, helping to prevent wheezing, shortness of breath, and airway obstruction.

Formonide 200 Inhaler contains Formoterol Fumarate (6mcg) and Budesonide (200mcg), making it an effective combination inhaler for asthma and chronic obstructive pulmonary disease (COPD) management. Formoterol: A long-acting bronchodilator (LABA) that relaxes airway muscles, improving airflow and preventing airway constriction. Budesonide: A corticosteroid that reduces inflammation in the lungs and prevents asthma attacks. Formonide 200 is recommended for long-term asthma control and COPD maintenance, preventing wheezing, shortness of breath, and respiratory inflammation.

Formonide 200 Respicaps contain Formoterol Fumarate (6mcg) and Budesonide (200mcg), designed for use with a DPI (Dry Powder Inhaler). This combination therapy is essential for long-term asthma management and chronic obstructive pulmonary disease (COPD) control. Formoterol (LABA): A long-acting bronchodilator that relaxes airway muscles, helping to improve airflow. Budesonide (ICS): A corticosteroid that reduces airway inflammation, preventing asthma symptoms and COPD flare-ups. This medication is not a rescue inhaler but is intended for daily maintenance therapy to improve lung function and prevent respiratory symptoms.

Foracort 400 Inhaler is a combination therapy inhaler containing Formoterol Fumarate (6mcg) and Budesonide (400mcg), specifically designed to manage moderate to severe asthma and chronic obstructive pulmonary disease (COPD). This dual-action metered-dose inhaler (MDI) effectively controls airway inflammation and persistent breathing difficulties by combining a long-acting bronchodilator (Formoterol) with an inhaled corticosteroid (Budesonide). Formoterol acts as a long-acting beta-2 agonist (LABA), relaxing airway muscles and providing relief from bronchospasms for up to 12 hours. It ensures smooth breathing and improved airflow, making it effective in preventing nighttime asthma attacks and exercise-induced bronchospasms. Budesonide, a powerful corticosteroid, reduces lung inflammation, swelling, and mucus production, preventing chronic respiratory distress and recurrent asthma symptoms. Foracort 400 Inhaler is ideal for long-term respiratory management, reducing the need for emergency bronchodilators while improving lung function over time. It is not a rescue inhaler and should be used consistently to maintain optimal airway health.